The Food and Drug Administration advisory panel has voted to recommend a Moderna booster vaccine for people 65 and older, as well as for younger adults who are at high risk of severe illness.
Vaccination rates are increasing in the U.S., since the introduction of a number of vaccine mandates.
FSN's Caroline Malone reports.
IN: "An FDA Panel approved
OUT: "...Caroline Malone, Washington."
DUR: 41 seconds